M. A. Carroll

Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?

Scott A. McHam, David J. Adelstein, Lisa Rybicki et al. · Head & Neck · 2003 · 179 citations

Medicine, Oncology, Radiation Oncology +14

Multiagent Concurrent Chemoradiotherapy for Locoregionally Advanced Squamous Cell Head and Neck Cancer: Mature Results From a Single Institution

David J. Adelstein, Jerrold P. Saxton, Lisa Rybicki et al. · Journal of Clinical Oncology · 2006 · 148 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Maximizing Local Control and Organ Preservation in Stage IV Squamous Cell Head and Neck Cancer With Hyperfractionated Radiation and Concurrent Chemotherapy

David J. Adelstein, Jerrold P. Saxton, Pierre Lavertu et al. · Journal of Clinical Oncology · 2002 · 122 citations

Medicine, Oncology, Radiation Oncology +14

Ability of Positron Emission Tomography to Detect Residual Neck Node Disease in Patients With Head and Neck Squamous Cell Carcinoma After Definitive Chemoradiotherapy

Ann Tan, David J. Adelstein, Lisa Rybicki et al. · Archives of Otolaryngology - Head and Neck Surgery · 2007 · 72 citations

Medicine, Nuclear Medicine, Oncology +17

Phase II trial of gefitinib for recurrent or metastatic esophageal or gastroesophageal junction (GEJ) cancer

David J. Adelstein, Lisa Rybicki, M. A. Carroll et al. · Journal of Clinical Oncology · 2005 · 31 citations

Medicine, Oncology, Pharmacology +17